SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes

dc.contributor.authorSabadell Basallote, Joan
dc.contributor.authorAstiarraga, Brenno
dc.contributor.authorCastaño, Carlos
dc.contributor.authorEjarque, Miriam
dc.contributor.authorRepollés de Dalmau, Maria
dc.contributor.authorQuesada, Iván
dc.contributor.authorBlanco, Jordi
dc.contributor.authorNúñez Roa, Catalina
dc.contributor.authorRodríguez Peña, M. Mar
dc.contributor.authorMartínez, Laia
dc.contributor.authorJesus, Dario F. de
dc.contributor.authorMarroquí, Laura
dc.contributor.authorBosch, Ramon
dc.contributor.authorMontanya, Eduard
dc.contributor.authorSureda, Francesc X.
dc.contributor.authorTura, Andrea
dc.contributor.authorMari, Andrea
dc.contributor.authorKulkarni, Rohit N.
dc.contributor.authorVendrell, Joan
dc.contributor.authorFernández Veledo, Sonia
dc.date.accessioned2024-09-03T07:39:31Z
dc.date.available2024-09-03T07:39:31Z
dc.date.issued2024-05-07
dc.date.updated2024-07-11T08:07:40Z
dc.description.abstractPancreatic beta cell dysfunction is a key feature of type 2 diabetes, and novel regulators of insulin secretion are desirable. Here, we report that succinate receptor 1 (SUCNR1) is expressed in beta cells and is upregulated in hyperglycemic states in mice and humans. We found that succinate acted as a hormone -like metabolite and stimulated insulin secretion via a SUCNR1-GqPKC-dependent mechanism in human beta cells. Mice with beta cell-specific Sucnr1 deficiency exhibited impaired glucose tolerance and insulin secretion on a high -fat diet, indicating that SUCNR1 is essential for preserving insulin secretion in diet -induced insulin resistance. Patients with impaired glucose tolerance showed an enhanced nutrition -related succinate response, which correlates with the potentiation of insulin secretion during intravenous glucose administration. These data demonstrate that the succinate/SUCNR1 axis is activated by high glucose and identify a GPCR-mediated amplifying pathway for insulin secretion relevant to the hyperinsulinemia of prediabetic states.
dc.format.extent15 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1558-8238
dc.identifier.pmid38713514
dc.identifier.urihttps://hdl.handle.net/2445/214943
dc.language.isoeng
dc.publisherAmerican Society for Clinical Investigation
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1172/JCI173214
dc.relation.ispartofJournal of Clinical Investigation, 2024, vol. 134, num. 12
dc.relation.urihttps://doi.org/10.1172/JCI173214
dc.rightscc by (c) Sabadell Basallote, Joan et al, 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationDiabetis
dc.subject.classificationMetabòlits
dc.subject.otherDiabetes
dc.subject.otherMetabolites
dc.titleSUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
JCI173214.v2.pdf
Mida:
6.98 MB
Format:
Adobe Portable Document Format